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Calcific tendinopathy of the rotator cuff 
 
Kalcifirajuća tendinopatija rotatorne manšete 
 




The calcific tendinopathy of the shoulder is characterized by the presence of macroscopic deposits of 
calcium hydroxyapatite in the tendons of the rotator cuff, spontaneous resorption of those deposits and, 
consequently, the tendon healing. The evolution of calcification is divided into 4 phases: formation of the 
calcium deposits, resting phase, resorption phase and post-calcific stage. The incidence of this condition is, in 
the general population, 8-20% with the peak of incidence at the ages between 30 and 50. The calcific 
tendinopathy mostly affects the tendon of the supraspinatus. It affects women more often than men and right 
shoulder more often than left. The bilateral presentation of calcific tendinopathy occurs from 5 to 23% of 
patients. Different theories about etiopathogenesis of the calcific tendinopathy were described and discussed. 
In recent years, there have been few publications presenting chondral metaplasia as an important mechanism. 
Radiological and ultrasound diagnostics are the most widely used diagnostic techniques. Magnetic resonance 
imaging and computed tomography are rarely used, just in clinically unclear cases. Conservative treatment 
includes non-steroidal anti-inflammatory drugs (NSAIDs), subacromial administration of the corticosteroids, 
physical therapeutic intervention, needle aspiration and lavage. In patients refractory to conservative 
treatment, surgical treatment, primarily arthroscopy, is indicated. Defining the stage (phase) of calcific 
tendinopathy determines the treatment method and prognoses the course of the disease. Precisely defining the 
phase enables avoiding unnecessary long-lasting physical therapy and also provides using the most effective 
treatment. 




Kalcificirajuću tendinopatiju ramena karakterizira prisutnost makroskopskih depozita kalcijeva 
hidroksiapatita u tetivama rotatorne manšete, spontana resorpcija kalcifikata i posljedično cijeljenje tetive. 
Evolucija kalcifikata podijeljena je u 4 faze: formativna, razdoblje mirovanja, razdoblje resorpcije, te 
naposljetku postkalcificirajuća faza.  
Incidencija kalcificirajuće tendinopatije ramena je u općoj populaciji 8-20%. Najviša incidencija je u 
odraslih u dobi od 30 do 50 godina. Najčešće mjesto kalcifikata je tetiva supraspinatusa, a rjeđe u ostalim 
tetivama rotatorne manšete. Žene su pogođene nešto češće od muškaraca, a desno rame nešto češće nego 
lijevo. Bilateralna prezentacija kalcificirajuće tendinopatije pojavljuje se u 5 do 23% bolesnika. Postoje 
različite teorije o etiopatogenezi, a posljednjih godina publiciraju se radovi koji govore o hondralnoj 
metaplaziji. U kliničkoj dijagnostici kalcificirajuće tendinopatije najviše se koristi radiološka i ultrazvučna 
dijagnostika. Magnetska rezonanca i kompujterizirana tomografija koriste se rijetko kod klinički nejasnih 
slučajeva. Konzervativno liječenje obuhvaća primjenu nesteroidnih protuupalnih lijekova (NSAID), 
subakromijalnu aplikaciju steroida, fizikalne terapijske intervencije, aspiraciju iglom i lavažu. U bolesnika 
refraktornim na konzervativno liječenje, indicirano je kiruško liječenje, prvenstveno artroskopsko.  
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Definiranjem stadija (faze) kalcificirajuće tendinopatije određuje se način liječenja, te prognozira tijek 
bolesti. Točnim definiranjem faza izbjegava se nepotrebna dugotrajna fizikalna terapija, a ujedno omogućava 
učinkovito liječenje, ovisno o stadiju bolesti. 




Definition of the calcific tendinopathy 
 
The calcific tendinopathy (CT) of the shoulder is 
characterized by the presence of macroscopic deposits 
of calcium hydroxyapatite in the tendons of the rotator 
cuff, the spontaneous resorption of the deposits and, 
consequently, the tendon healing.1 The reasons why 
calcification occurs are unclear. The possible causes 
include ischemia, metabolic disorders and fibro-
cartilage transformation of the tendon tissue. During 
the resorption of calcific deposits, patients may 
experience acute symptoms, including severe pain and 
limitation of mobility, usually duration up to two 
weeks. However, if, due to the size of the deposits, 
subacromial impingement syndrome occurs, a state 
may become chronic.2 Uhthoff Loehr described the 
calcific tendinopathy as a disease undergoing several 
phases: Formation of the calcium deposits: As a result 
of an unknown trigger, part of the tendon undergoes 
fibrocartilaginous transformation and, consequently, 
calcium deposits are formed. In this phase, symptoms 
are insignificant, just in the form of discomfort. By the 
time, deposits become bigger. Resting phase: Once 
created, a calcium deposit enters the resting period. 
Resorption phase: This phase starts with an 
inflammatory response. On the peripheral parts of the 
deposits, vascular tissue is generated. Macrophages 
and multinuclear giant cells reabsorb the deposits. 
Patients experience a severe pain and a limitation of 
mobility. Post-calfic phase: After the resorption, the 
collagen in tendons is reconstructed by fibroblasts 




Picture 1 Phases/ Slika 1. Faze Normal tendon/Normalna tetiva/ Precalcific stage/ Prekalcificirajuća faza/ 
Fibrocartil metaplasia/ Fibrokalrtilaginozna metaplazija/ Formative faze/Formativna faza/ Pain/Bol/ Resting 
period/Razdoblje mirovanja/ Calcific stage/ Kalcificirajuća faza/ Resorptive phase/ Resorptivna faza/ Tendon 
reconstitution/ Rekonstrukcija tetive/ Postcalcific stage/ Postkalcificirajuća faza 
 
Med Jad 2021;51(1):77-88 
 
Cesarec G et al. Calcific tendinopathy of the rotator cuff   – Med Jad 2021;51(1):77-88 
 
 79 
The two main characteristics differentiate the CT 
from degenerative calcification: in calcific tendino-
pathy, calcification is a cellular induced process in 
living tissue, unlike degenerative calcification where 
calcium salts are precipitated into a degenerative 
changed tendon, bounded to the bone. Histological and 
immunohistochemical evidence of cellular-induced 
resorption is supported by the clinical observation of 
spontaneous resorption of deposits, a phenomenon that 
never occurs in degenerative calcification.4 There are 
four key histological findings: fibrocartilaginous 
metaplasia during a pre-calcific phase, deposits of 
calcium crystals in the fibrocartilaginous matrix during 
the formative phase, the cellular mediated resorption 
of deposits during the resorption phase and tendon 
restitution during post-calcific phase.5 Calcific 
tendinopathy is a multifocal, cellular-mediated process 
in which the metaplastic transformation of tenocytes 
induces a calcification within the tendon. After that, 
the metaplastic areas are phagocyted by multinuclear 
giant cells. The tendon is reshaped and reformed into a 
normal tendon. 
 
Epidemiology and pathogenesis of the calcific 
tendinopathy 
 
Reports of the total frequency of calcific 
tendinopathy vary significantly. The incidence of the 
calcific tendinopathy of the shoulder is, in the general 
population, 8-20% with the peak of incidence at the 
ages between 30 and 50.1 The calcific tendinopathy 
mostly affects the tendon of the supraspinatus muscle; 
infraspinatus, subscapularis and the teres minor 
tendons are rarely affected, less than 10% of the 
calcific tendinopathy includes the subscapular 
tendinopathy.6 It affects women more often than men, 
and the right shoulder more often than left. The 
bilateral presentation of calcific tendinopathy of the 
shoulder is not uncommon and occurs from 5 to 23% 
of patients.7-9 The etiology of the calcific tendinopathy 
remains unknown. Possible pathoetiological factors 
are inflammation, degeneration, fibrocartilaginous 
transformation, overload or insufficient load, repetitive 
motion, external irritation, a combination of internal 
and external factors, postural variations, nutritional 
and systemic factors and genetics.3 It is very likely that 
pathoetiology and pathohistology of pain and 
dysfunction of the tendons of the rotator cuff are 
complex and multifactorial. There are different 
theories about etiopathogenesis. In recent years, there 
have been few publications presenting chondral 
metaplasia as an important mechanism.10 Pre-clinical 
and clinical studies have clearly shown that the 
formation of the calcium deposits in calcific 
tendinopathy is a cellular induced process. The 
possible pathogenetic mechanism of the heterotopic 
ossification is a disturbed differentiation of the stem 
cells of the tendon origin.11 The mechanical overload 
or repeated microtrauma leads to an increased 
expression of the bone morphogenetic protein (BMP-
2), and increase in the activity of the alkaline 
phosphatase which leads to a disturbed differentiation 
of the stem cells in chondorcytes and osteoblasts 
instead of differentiation in tenocytes. BMP-2 was 
detected as a key element in the pathogenesis of 
calcific tendinopathy.12 On the animal models, it has 
been shown that the injection of the recombinant 
human bone morphogenetic protein (rhBMP) in the 
tendons leads to the ectopial bone formation.13  
Recent studies have demonstrated the presence of 
thyroid receptors in tenocytes.14 Their role in the 
proliferation and apoptosis of the tenocytes has not yet 
been determined. Hypothyroidism causes the accumu-
lation of glycosaminoglycans in the extracellular 
matrix, which may facilitate the calcification in the 
tendon.15 Sengar et al. discovered a correlation 
between the HLA-A1 gene and calcific tendinitis, 
indicating the genetic predisposition of the disease.16 
Further investigations should determine the possibility 
of incorrect transdifferentiation of the tendon 
fibroblasts and the role of mechanical load, growth 
factors, cytokines and extracellular matrix in the 
pathogenesis of this disease. Furthermore, an 
association between calcific tendinopathy and diabetes 
has been observed; there are reports in which > 30% of 
patients with insulin-dependent diabetes have 
calcifying deposits in tendons. There are also reports 
that patients with associated thyroid disorders show 
earlier symptoms, longer duration of the disease, and 
undergo surgery more easily than others undergo, but 
the precise mechanism is still unclear. An increased 
incidence of class A1 human leukocyte antigen serotype 
was observed in patients with calcific tendinopathy, 
suggesting a possible genetic predisposition to the 
disease.17 
 
Clinical diagnosis of calcific tendinopathy 
 
     The initial stage of the formation of calcium 
deposits causes minor symptoms in the form of 
discomfort. Vascular proliferation occurs during the 
resorption of the deposits and, consequently, an 
increase in the intertendinous pressure, causing pain. 
Due to the increase in the volume of the tendon, it 
collides with the coracoacromial arch and causes more 
pain. During the formative phase, the patient 
complains of pain and local sensitivity that irradiates 
in the area of the deltoid muscle. Shoulder mobility is 
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reduced due to pain; the patient cannot lie on the 
affected side. During the acute resorption phase, the 
pain is so severe that the patient keeps his hand to the 
body and does not allow any movement.18 The pain can 
become chronic which is associated with the size of the 
deposits and the development of the subacromial 
impingement syndrome.19 
 
Radiological diagnostics of calcific tendinopathy 
 
A standard radiograph in an antero-posterior view 
and recordings in internal and external rotation enables 
localization and evaluation of texture and morphology of 
deposits. The deposit of calcium in the acute (resorption) 
phase is blurry, poorly limited, and inhomogeneous. In a 
chronic, formative phase, the deposit is dense, well-





Picture 2 X-ray in AP view and in internal rotation, resorptive phase (original data) 






Picture 3 X-ray of the same patient, one year later (original data) 
Slika 3. Radiološka snimka istog bolesnika, godinu dana kasnije (vlastiti izvor) 
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There are various radiological classifications based 
on the size of deposits, the morphology of the deposits 
and the stage of the disease. Several classifications 
have been proposed. However, the fact that there are 
many classifications indicates that there is no 
classification which perfectly corresponds to the radio-
logical image and the symptomatology of the patient. 
DePalma distinguishes two types of the calcific 
tendinopathy: Type I: flaky and amorphous, type II: 
defined and homogenous. Type I is most common in 
patients with acute symptoms, and type II is commonly 
found in patients with chronic symptoms.21 
The French Arthroscopic Society has defined 4 
types of deposits: 
Type A: sharp lines, dense and homogenous 
Type B: sharp line, thick and of multiple fragments 
Type C: heterogeneous appearance, flaky 
Type D: distrophytic calcification at the insertion 
point of the tendon 
Gärtner proposed a classification: Type I with sharp 
lines and dense structure, type II with blurry lines and 
transparent structure and type III with characteristics 
of both of these types.22 
 
Ultrasound in diagnostics of calcific tendinopathy 
 
In recent years, ultrasound has become an 
important method of reviewing and monitoring 
patients with damaged movement system because it is 
widely available, inexpensive, displays changes in 
para-articular structures, inflammatory changes in the 
sinovia and swelling in the joint, muscles, tendons and 
the surface of the bone. Ultrasound is a diagnostic 
method that can accurately determine the size and 
localization of calcium deposits. It has the advantage 
in diagnoses because it helps to detect other related 
conditions such as rotator cuff rupture and 
tendovaginitis of the long head of the biceps muscle. 
The deposits of calcium are shown as a hyper-
echogenic focus in the rotator cuff tendons. The 
presence of the acoustic shadow depends on the 
density and size of the calcification. The homogenous 
calcification in the chronic phase is clearly visible as a 
hyperechogenic focus which makes an acoustic 
shadow. The inhomogeneous calcification in the acute 
phase contains a lower amount of calcium and is 
shown by decreased echogenicity.19 According to the 
morphology of calcifications, ultrasound was used to 
classify different types of calcifications. Chiou et al. 
describe four forms of the deposits: arch-shaped 
(hyperechogenic arch with shadow), fragmented or 
puncture-shaped (at least two separated echogenic 
places with or without shadow), nodular-shaped 
(echogenic node without shading) and cystic-shaped 
(thick echogenic wall with an anechogenic area or 
layered content).23 
 
Doppler in diagnostics of calcific tendinopathy 
 
The Doppler can reveal vascularization, and 
numerous publications were published in which color 
and power Doppler are used to detect, visualize and 
quantify changes in the vascularization of joints in 
various inflammatory diseases of the musculoskeletal 
system.24,25,2,19 
The Doppler shows increased vascularization 
around the deposits in certain disease phases which 
corresponds to the histopathological findings such as 
phagocytosis in the reabsorption phase and a 
proliferation of the vascular channels around the 
deposits, described in the paper of Uthoff and co 
(Picture 4).3  
 
Magnetic Resonance Imaging 
 
The MRI should not be used as the first diagnostic 
choice, because the deposits appear as unclear areas of 
low-intensity signals on the T1 and T2 images, or may 
not be recognized. The MRI is an additional, but not an 
essential tool, considering that in most cases it does not 
provide any additional information. The areas of 
increased intensity can be found around the deposits in 
the T2 view and indicate the edema around the deposits 
in the resorption phase, which can be misinterpreted as 
a rotator cuff rupture.26 Amorphous deposits may be 





It has an excellent resolution for detecting deposits, 
but the cost and the exposure to the radiation restrict its 
use. Computerized tomography is indicated in cases 
where ultrasound diagnostics are unavailable or when 
the sonography is negative and does not agree with the 
positive clinical findings or in younger patients after 




The first-line therapy is a conservative treatment 
involving non-steroidal anti-inflammatory drugs 
(NSAIDs), subacromial administration of the 
corticosteroids, physical therapeutic intervention, 
needle aspiration, and lavage. In patients with severe 
pain and dense well-limited calcium deposits, refractory 
to conservative treatment, surgical treatment is 
indicated, primarily arthroscopy, sometimes combined 





Picture 4 Positive power Doppler in the resorptive phase (original data) 
Slika 4. Pozitivan nalaz power Dopplera u resorptivnoj fazi (vlastiti izvor) 
 
with acromioplasty and/or reconstruction of the rotator 
cuff. The first goal of treatment is to release pain using 
physical modalities to reduce pain and inflammation. 
After the inflammation is reduced, the next step is 
preservation and regeneration of movement and 
strengthening of the muscles. The ultimate goal of 
rehabilitation is to achieve functional restitution of the 
affected shoulder and to enable the patient to perform 
daily activities without restriction. The predictors of 
poor prognosis are female sex, affected dominant arm, 
bilateral disease, longer duration of symptoms (> 3 
months) and multiple calcifications, and, according to 
some authors, localization of deposits in the front part of 
the acromion and the existence of subacromial 
impingement.28,29 The treatment approach depends on 
the severity of the symptoms and the patience of the 
doctor and the patient (Table 1).
Table 1 Therapeutic approach algorithm 
Tablica 1. Algoritam terapijskog pristupa 
 
Therapy/ Terapija Effect/Učinci 
Chronic pain/ Kronična bol   
Conservative treatment: avoid corticosteroids 
Konzervativna terapija; izbjegavati kortikosteroide 
Surgical procedure: if conservative treatment is ineffective, if pain 
interferes with ADL 
Operativno liječenje ako je konzervativna terapija neuspješna i ako 
postoje ograničenja za rad i ADL 
Maintain ROM and strength 
Održavati opseg pokreta i snagu 
Acute pain/Akutna bol  
Needling and lavage/Needling i ispiranje Decompression/Dekompresija 










The usage of non-steroidal anti-inflammatory drugs 
is indicated in the acute and subacute stages. An anti-
inflammatory dose is applied in a period of 5-10 days. 
In the case of chronic symptoms, NSAIDs are 
prescribed as needed. Other analgesics are rarely 





     Local subacromial injections of corticosteroids are 
used in the acute phase and reduce pain 
significantly.32,33 Local intrabursal corticosteroid 
injections are not used in patients with chronic 
symptoms. If there is a subacromial impingement 
syndrome, corticosteroid injection is applied with a 
lidocaine. Subacromial injections have several 
advantages: cheap treatment, low risk of complications 
and regression of the symptoms after a short period. 
 
Physical therapeutic interventions 
 
Extracorporeal shockwave therapy (ESWT) 
 
In the last 25 years, ESWT has been successfully 
used in people with tendon and muscle diseases.34,35 
The application of a shockwave in the treatment of 
calcific tendinopathy was firstly described by Dahmen 
in 1992.36 Shockwaves can be generated by 
electrohydraulic, electromagnetic or piezoelectric 
mechanisms. The high amplitude pressure pulse is 
generated outside the patient's body and energy is 
focused on the target area of the body. There are two 
types of the shockwave applicator: focused and radial. 
Kinetic energy is transformed into the acoustic wave 
energy of high amplitude, short duration and sudden 
increase in pressure. Focused shock waves converge 
into a focal point or spot. The penetration depth can be 
precisely determined in a zone between 5-60mm below 
the skin surface, depending on the applicator diameter 
and frequency. In non-focused radial shockwave 
therapy the energy from the surface of the applicator 
radially extends into the tissue. The largest energy is 
on the surface of the applicator and is proportionally 
reduced to the maximum depth of up to 35mm. The 
destructive potential of the shockwave is thus not 
exploited as much as the ability of a shockwave to 
cause hyperemia. The aim of the treatment is to 
intensify vascularization and to promote the natural 
washout of the organism.37 The mechanism by which 
ESWT produces a clinical effect is still unknown. 
Several theories are suggested: a mechanical effect that 
causes fragmentation of deposits, a molecular effect 
with induction of inflammatory response with 
neovascularization, chemotactic activity and 
phagocytosis, and analgesic efficacy and inhibition of 
serotonergic system activation and peripheral 
denervation. The biological effects of the shockwave 
therapy are hyperemia, angiogenesis, and stimulation 
of fibroblasts, tenocytes, osteoblasts and chondorcytes, 
and mechanism of mechanical destruction. The overall 
effect on the target tissues is probably achieved by the 
combination of described effects.38-44  
In the paper written by Farr and co., energy of the 
waves is classified as a low energy (below 0.08 
mJ/mm2), medium energy (0.08-0.28 mJ/mm2) or high 
Corticosteroid injections/Jedna kortizonska injekcija Reduce phagocytosis, reduce 
hyperemia/Smanjenje fagocitoze; 
smanjenje hiperemije 
ROM exercises/Vježbe opsega pokreta Prevent development of „frozen 
shoulder“/Spriječiti pojavu „smrznutog 
ramena“ 
Subacute pain/Subakutna bol  
Abduction/ Mirovanje u abdukciji Reduce the pressure, increase the blood 
flow/Istezanjem smanjiti pritisak. 
povećati protok krvi 
 
ROM and strength exercises/Vježbe opesga pokreta i jačanja Prevent development of „frozen 
shoulder“ and strength loss/ Spriječiti 
pojavu smrznutog ramena i slabosti 
mišića 
Avoid corticosteroids/Izbjegavati kortikosteroidne injekcije  
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energy (0.28-0, 60 mJ/mm2).39 The side effects 
reported as a result of the activity of ESWT between 
0.04 and 0.22 MJ / mm2 are very rare, such as pain, 
local soft tissue edema, skin erosion, erythema, 
petechial hemorrhage, and subcutaneous hematoma. If 
high energy ESWT is applied, local anesthesia is 
required. In literature, there is only one case of 
osteonecrosis of the head of the humerus after the 
ESWT.45 Contraindications for ESWT are divided into 
general and local contraindications. General 
contraindications are infections, implanted electrical 
stimulator, pregnancy and local tumor. Local 
contraindications are avascular necrosis of the head of 
the humerus, heterotopic ossification, ostomyelitis and 
non fused growth plates. 
Several studies have confirmed the benefits of 
ESWT for the treatment of calcific tendinopathy of the 
shoulder. It is noted that high energy ESWT (EFD ≥ 
0.28 mJ/mm2) is more effective than low energy 
ESWT (EFD < 0.28 mJ/mm2) in improving shoulder 
function and reducing pain. Gerdesmayer et al. 
conducted a study on 144 patients treated with 
randomized energy (high or low). Both types of ESWT 
resulted in significant improvements in the 6-month 
evaluation, but higher ESWT energy resulted in better 
results. Measured with Constant Murley Score 
(CMS)46,47 by analyzing 54 randomized clinical trials, 
it was found that the usage of focused and radial 
ESWTs was effective when applying high levels of 
energy, leading to pain reduction and deposit 
resorption with a better response of type II patients to 
the Gartner Classification.48 It has also been found that 
the results are comparable to the results achieved by 
surgical procedure. The role of ESWT as one of the 
physical therapies can only be discovered by further 
well-designed researches. Phase-dependent indications 
(formative, resorptive phase) are still not clearly 
defined. 
 
 Therapeutic ultrasound 
 
     Some studies have reported the efficacy of 
ultrasound therapy: pain relief and functional 
improvement within 2 months of application.49 There 
are also studies in patients with calcific tendinopathy 
where ultrasound therapy has not achieved greater 
effect than placebo.50 There is no evidence of 





In pain management, the laser is a generally 
accepted modality although, due to the inability to 
define the mechanism of pain suppression, some 
doubts about the actual effect are present.52,53 Laser 
photons are absorbed by chromophores, resulting in 
target heating and localized damage. Laser irradiation 
alters cellular metabolism and cellular functions.54 
Usage of lasers in the treatment of shoulder pain has 
more efficacy than placebo. However, there is no 
difference between the usage of laser therapy + 




Transcutaneous electrical stimulation (TENS) is 
useful for pain relief in the acute phase.55 The results 
of the Cochrane review, "Physiotherapy interventions 
for shoulder pain", where the synthesis of available 
evidence of the advantages and disadvantages of 
electrotherapy modalities for the treatment have not 
shown that TENS or any other electro-procedure, such 
as low-intensity laser, ultrasound, pulse 





     Well-conceived therapeutic programs have the goal 
of reducing pain, reflecting/increasing the range of 
motion, and achieving/maintaining independence in 
daily activities. In an acute phase, physical activity 
should be reduced to avoid damaging healthy 
anatomical structures. After pain relief, therapeutic 
exercises should be prescribed: passive and active 
assistive to increase the range of motion. Later, the 
introduction of resistance training exercises is required 
to strengthen the muscles of the rotator cuff. 
Therapeutic exercise programs, if they are well-
conceived, can lead to improvements similar to those 
achieved by surgery. Simple range of motion exercises 
and resistance exercises performed at home with 
periodic professional examination can be more 
effective than intense physiotherapy.57 
 
Ultrasound-guided percutaneous aspiration and 
washing (needling and lavage) 
 
     Lavage can be effective only in the case of 
radiological or ultrasound proved resorption. 
Ultrasound-guided fine needle aspiration procedure is 
preferred for better results. Some authors suggest 
administration of corticosteroids, while others warn 
that corticosteroids prevent vascular proliferation, 
local hyperemia, and macrophage activity, which 
returns calcium deposits to the resting phase. De Witte 
et al. described the differences between groups of 
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patients treated with ultrasound-induced percutaneous 
aspiration and lavage and groups of patients treated 
with administered subacromial corticosteroid 
injection. After one year of treatment, the function was 
evaluated by Constant Murley Score (CMS) and better 
results were observed in a group of patients treated 
with needling and lavage. Furthermore, in patients 
treated with percutaneous aspiration (13 out of 23 
patients), full resorption occurred more frequently than 
in those treated with corticosteroid injection.58 The 
Cochrane review on 1450 patients established that 
ultrasound-guided percutaneous aspiration of the 
deposits is a safe and effective procedure with an 
estimated significant reduction in pain.29 
Systemic review and meta-analysis of comparison 
of ESWT, ultrasound-guided percutaneous lavage - 
UGPL, corticosteroid injections and combined 
treatments showed that UGPL + corticosteroid 
injections treatment achieved the best results, 
according to CMS, visual analog scale and the 
decrease in deposit size.59 
 
Other forms of treatment 
 
Platelet-rich plasma – PRP 
 
Platelet-rich plasma has become a popular option 
for the treatment of injured tendons. The efficacy of the 
PRP therapy in rotator cuff calcific tendinitis is 
uncertain. In literature, there are only a few studies 
regarding PRP application in rotator cuff tendinopathy. 
Future studies will standardize the preparation and 
frequency of PRP injections in this condition. The PRP 
injection can be an effective treatment option, 
especially in refractory cases of rotator cuff calcific 
tendinitis.60 Rha et al found that the effects of PRP 
injection on shoulder pain and function exceeded those 
of dry needling in a 6-month follow up. By contrast, 
Kesikburun et al. have compared the effects of PRP to 
placebo effects and found no significant difference 
between them in pain relief and functional 
improvement.61 Seijas et al. presented a case of a 44-
year-old woman treated with platelet-rich plasma 
injections (three treatments applied at two-week 
intervals). All previous treatments in these patients 
failed. Regression of symptoms occurred within six 




     Approximately 10% of patients are resistant to the 
conservative treatment and, for those patients, an 
operation is required. Surgical treatment is indicated in 
patients with severe symptoms lasting more than six 
months. Two types of surgical procedures are 
available: arthroscopic removal of calcium deposits 
and open surgery, which have become less frequently 
used in recent years.63-65 Indications for the surgery are 
symptom progression, constant pain that interferes 
with daily activities and the absence of reduction of 
symptoms after conservative therapy. Recovery time 
after surgery is surprisingly long, in 30% pain and 





     Arthroscopy has become a commonly used 
technique for removing calcium deposits, although the 
arthroscopic approach is demanding. There are several 
possible advantages over open surgery: less pain, 
visualization of additional pathology, and a potentially 
shorter recovery period after surgery. Subacromial 
decompression is performed only when in presence of 
some additional pathology, such as a sharp acromion, 
osteophytes or subacromial syndrome. Arthroscopic 
removal of calcium deposits without acromioplasty 
yields results in a rapid pain relief, regardless of 
acromion morphology. Recovery of the functions 
requires almost 3 months.67,68 Postoperatively, the 
range of motion is maintained. Rehabilitation consists 
of a range of motion exercises 24 hours after 
arthroscopy, first passive exercises, than combined 
with active assistive. Based on the patient's ability, 
active exercises are introduced on the third day. 
Patients may return to work after 3 months, and full 
functional recovery is achieved in 6 months. 
Arthroscopy is a gold standard for surgical treatment, 
but two questions remain: whether acromioplasty is 
needed and is it required to completely remove a 
deposit.69 
The senior author, orthopaedic shoulder surgeon 
(NC) in the last 10 years artroscopically removed 
calcium deposit without acromioplasty in 159 patients. 
Acromioplasty is not needed during removal of 
calcium deposit from the tendon and authors do not 
recommend acromioplasty in patients with calcium 
deposit. In the follow up of patients, we recommend 
using VAS pain or Numeric pain scale for pain 
assessment, inclinometer for range of motion 
measuring and Constant Shoulder score, Oxford 
shoulder score and Quick- DASH (short version of the 
questionnaire Disabilities of the arm, shoulder and 










    The successful treatment of patients with calcific 
tendinopathy depends on the understanding of the 
pathophysiology of the disease. It is proven, in various 
clinical observations, that spontaneous resorption 
exists, but the cause of the resorption remains unclear. 
The influence of morphology of certain calcium 
deposits on the symptoms, pain and disturbed function, 
should be differentiated, which would help to 
distinguish the phase of the calcific tendinopathy. 
There is also a great importance in determining the 
correlation between the radiological and ultrasound 
characteristics of the deposit and the positive color and 
power Doppler and clinical finding. The introduction 
of Doppler findings in the follow-up algorithm is 
significant. Accurately staging of the disease enables 
avoiding unnecessary long-lasting physical therapy 
and usage of effective treatment. 
Factors responsible for fibrocartilaginous 
metaplasia, as well as those that trigger the resorption 
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